iifl-logo-icon 1

Innova Captab Ltd Share Price

586.05
(5.01%)
Jul 22, 2024|01:59:55 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open564.8
  • Day's High598.3
  • 52 Wk High588
  • Prev. Close558.1
  • Day's Low549.2
  • 52 Wk Low421.35
  • Turnover (lac)1,590.11
  • P/E46.67
  • Face Value10
  • Book Value120.21
  • EPS11.91
  • Mkt. Cap (Cr.)3,353.67
  • Div. Yield0
No Records Found

Innova Captab Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

564.8

Prev. Close

558.1

Turnover(Lac.)

1,590.11

Day's High

598.3

Day's Low

549.2

52 Week's High

588

52 Week's Low

421.35

Book Value

120.21

Face Value

10

Mkt Cap (₹ Cr.)

3,353.67

P/E

46.67

EPS

11.91

Divi. Yield

0

Innova Captab Ltd Corporate Action

20 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Innova Captab Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Innova Captab Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|02:19 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 50.89%

Foreign: 0.00%

Indian: 50.89%

Non-Promoter- 22.42%

Institutions: 22.42%

Non-Institutions: 26.67%

Custodian: 0.00%

Share Price

Innova Captab Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

48

12

12

12

Preference Capital

0

0

0

0

Reserves

220.32

198.83

132.82

98.35

Net Worth

268.32

210.83

144.82

110.35

Minority Interest

View Balance Sheet
Loading...

No Record found

View Profit & Loss
Loading...

No Record found

View Cash Flow
Loading...

No Record found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,081.31

926.38

800.53

410.66

373.32

Excise Duty

0

0

0

0

0

Net Sales

1,081.31

926.38

800.53

410.66

373.32

Other Operating Income

0

0

0

0

0

Other Income

12.49

9.2

2.88

1.37

1.3

Innova Captab Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,568.65

123.313,76,323.69867.60.865,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,519.8

76.171,19,994.455310.662,259507.93

Cipla Ltd

CIPLA

1,485.5

32.291,19,928.541,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,144.45

33.511,15,173.541,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,636

25.851,10,759.071,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Innova Captab Ltd

Management

Register Office

Registrar Office

Whole-time Director

JAYANT VASUDEO RAO

Director

Shirish Gundopant Belapure

Director

SUDHIR KUMAR BASSI

Director

PRIYANKA DIXIT

Director

ARCHIT AGGARWAL

Company Secretary

Neeharika Shukla

Whole Time Director

MANOJ KUMAR LOHARIWALA

Managing Director

VINAY KUMAR LOHARIWALA

Director

MAHENDAR KORTHIWADA

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Innova Captab Ltd was incorporated as Harun Health Care Private Limited, dated January 3, 2005 at Mumbai. Thereafter, name of the Company changed from Harun Health Care Private Limited to Innova Captab Private Limited, and consequently, a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company. Subsequently, Company converted to a Public Company on July 12, 2018, and consequently, its name was changed to Innova Captab Limited, dated July 26, 2018.The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business. Their CDMO product portfolio spans across both acute and chronic therapeutic areas. These CDMO services and products include commercial large-scale manufacturing of generic products, which allow customers in offering multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, modified and release forms of tablets in capsules. It has 2 manufacturing facilities in Baddi, Himachal Pradesh. Their facilities further produce tablets, capsules, dry syrups, dry powder injections, ointments and liquid orals. In 2006, the first manuf
Read More

Company FAQs

What is the Innova Captab Ltd share price today?

Down Arrow

The Innova Captab Ltd shares price on N/A is Rs.₹579.7 today.

What is the Market Cap of Innova Captab Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Innova Captab Ltd is ₹3317.33 Cr. as of 22 Jul ‘24

What is the PE and PB ratio of Innova Captab Ltd?

Down Arrow

The PE and PB ratios of Innova Captab Ltd is 46.67 and 4.40 as of 22 Jul ‘24

What is the 52 Week High and Low of Innova Captab Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Innova Captab Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Innova Captab Ltd is ₹421.55 and ₹590 as of 22 Jul ‘24

What is the CAGR of Innova Captab Ltd?

Down Arrow

Innova Captab Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 1.96%, 6 Month at 2.60%, 3 Month at 18.25% and 1 Month at 12.16%.

What is the shareholding pattern of Innova Captab Ltd?

Down Arrow

The shareholding pattern of Innova Captab Ltd is as follows:
Promoters - 50.90 %
Institutions - 22.42 %
Public - 26.68 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.